
68,346 shares were sold for ~$684,143 on August 10, 2026. The transaction represents a 0.89% reduction in direct equity holdings.
Butterfly Network, Inc., a digital health company, develops, manufactures, and markets ultrasound imaging solutions in the United States and internationally. The company is headquartered in Guilford, Connecticut.
| Revenue (TTM) | $112.14M |
| Gross Profit (TTM) | $76.44M |
| EBITDA | $-46.82M |
| Operating Margin | -30.90% |
| Return on Equity | -35.50% |
| Return on Assets | -10.50% |
| Revenue/Share (TTM) | $0.44 |
| Book Value | $0.72 |
| Price-to-Book | 12.43 |
| Price-to-Sales (TTM) | 21.42 |
| EV/Revenue | 20.05 |
| EV/EBITDA | -9.57 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 39.50% |
| Shares Outstanding | $244.86M |
| Float | $218.49M |
| % Insiders | 10.15% |
| % Institutions | 61.19% |
Volatility is currently expanding

68,346 shares were sold for ~$684,143 on August 10, 2026. The transaction represents a 0.89% reduction in direct equity holdings.

Butterfly Network (BFLY) traces back to a not-so-modest aspiration of one co-founder, to change the world, and a fortunate introduction by his professor to a visionary tech entrepreneur. BFLY is doing that through its pioneering ultrasound on a chip. A scanner sends images to an iPhone or similar device. That makes ultrasound doable pretty much anywhere. That's a huge deal. Cumbersome logistics cause many to refrain from being scanned as regularly as they should, often to bad and sometimes tragic results.

Butterfly Network raises its 2026 outlook as Embedded revenues surge, enterprise POCUS expands, and Home and Community Care moves toward Q4 revenues.

Butterfly Network, Inc. (BFLY) Q2 2026 Earnings Call Transcript

Butterfly Network, Inc. (BFLY) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.06 per share a year ago.

BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced financial results for the second quarter ended June 30, 2026, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, "Butterfly delivered another outstanding quarter, exceeding the high end of our guidanc.

Butterfly Network's second-quarter results may hinge on rising iQ3 demand, Compass AI adoption and Embedded growth, as revenues are expected to climb 21.5%.

BFLY launches Butterfly iQ+ and iQ3 in Brazil, expanding its handheld ultrasound reach into a major Latin American medical device market.

Butterfly Network's partner Aleph Neuro showcases non-invasive 3D brain imaging, highlighting the reach of its Ultrasound-on-Chip platform.

BURLINGTON, Mass.--(BUSINESS WIRE)---- $BFLY #POCUS--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the commercial availability of its Butterfly iQ+ and iQ3 handheld ultrasound devices and mobile application in Brazil through a network of authorized distribution partners. Brazil is the largest medical device market in Latin America and one of the fastest-growing ultrasound markets globally,1,.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BFLY and any ticker you trade — then tracks every position and per-strategy win rate.